Cepheid

From 911Encyclopedia:

One of a few BioPharmacy companies, who profited most of the anthrax attack in October 2001 (See Anthrax-911-Gate). Cepheid, which was founded in early 1996, received a new bioDefense Budget in late 2001. Cepheid develops Rapid Analysis Techniques. These are testing products for genetic profiling, DNA purification, the detection of food and water contaminants, and other applications. The Smart Cycler, its flagship product, is a DNA amplification (rapid duplication) and detection system for life science research. Partners Fischer Scientific, Eurogentec, and Takara Shuzo sell the system in select markets in North America, Europe, and Asia, respectively. Another important project of Cepheid is GeneXpert®, a system designed to extract and examine DNA from blood samples. Other US Government partners of Cepheid are: USAMRMC (DNA analysis systems) http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/08-07-2000/0001284761&EDATE= Usamriid (GeneExpert, Dec.2001) http://www.techreview.com/magazine/dec01/talbot.asp Furthermore the Johns Hopkins's (->) Bloomberg School of Public Health, Intellitec (DeLand, FL), Battelle, MIT's Lincoln Laboratory and Cepheid are working together on an air sniffer system for worrisome pathogens. Sources: http://www.techreview.com/magazine/dec01/talbot.asp http://www.gyre.org/news/cache/1409

David Relman, who is on the Scientific Advisory Board of Cepheid, has served on advisory panels for the Infectious Diseases Society of America, NIH, FDA, American Society for Microbiology, Defense Advanced Research Projects Agency (DARPA)->, and the Department of Defense (See DoD) Sources: http://www.cepheid.com/ http://www.cepheid.com/pages/management.html